SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934
                                 Amendment No. 2
                                    --------
                       California Coastal Communities Inc.
 -------------------------------------------------------------------------------
                                (Name of Issuer)

                                  Common Stock
 -------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    129915203
 -------------------------------------------------------------------------------
                                 (CUSIP Number)

                      Mellon HBV Alternative Strategies LLC
                           200 Park Avenue, 54th Floor
                             New York, NY 10166-3399
                                 (212) 922-8200
 -------------------------------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)

                                  October 16, 2006
 -------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box.

Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).







         CUSIP No. 148435100
-------------------------------------------------------------------------------
         1        NAME OF REPORTING PERSONS
                  I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
                  Mellon HBV Alternative Strategies LLC
-------------------------------------------------------------------------------
         2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ](b)[ ]
------------- -----------------------------------------------------------------
         3        SEC USE ONLY
-------------------------------------------------------------------------------
         4        SOURCE OF FUNDS*
                  WC
--------------------------------------------------------------------------------
         5        CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
                  PURSUANT TO ITEMS 2(d) OR 2(e)      [ ]
--------------------------------------------------------------------------------
         6        CITIZENSHIP OR PLACE OF ORGANIZATION
                  Delaware
--------------------------------------------------------------------------------
         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
--------------------------------------------------------------------------------
         7        SOLE VOTING POWER
                  1,003,768
--------------------------------------------------------------------------------
         8        SHARED VOTING POWER
                  0
--------------------------------------------------------------------------------
         9        SOLE DISPOSITIVE POWER
                  1,003,768
--------------------------------------------------------------------------------
        10        SHARED DISPOSITIVE POWER
                  0
-------------------------------------------------------------------------------
        11        AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON
                  1,003,768
-------------------------------------------------------------------------------
         12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
                  SHARES (see Instructions)             [ ]
-------------------------------------------------------------------------------
         13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  9.9  %
-------------------------------------------------------------------------------
         14       TYPE OF REPORTING PERSON (see Instructions)
                  IA
-------------------------------------------------------------------------------

INTRODUCTION:

Mellon  HBV  Alternative  Investment  Strategies  LLC, a  registered  investment
adviser (the "Reporting Person"),  on behalf of affiliated  investment funds and
separately  managed  accounts over which it exercises  discretionary  authority,
beneficially  owns 9.9% of the Common Stock of California  Coastal  Communities
Inc. (the "Company").

The Reporting  Person is filing this amendment no. 2 to Schedule 13D to disclose
recent sales by the Reporting Person.


ITEM 4.  PURPOSE OF TRANSACTION.

     The Reporting  Person,  for itself and for affiliated  investment funds and
separately  managed  accounts over which it exercises  discretionary  authority,
acquired the Shares for investment purposes.

     The Reporting Person is filing this amendment to report recent sales of the
Company's Common Stock

     The  Reporting  Person  reserves  the right to continue  to acquire  and/or
dispose of securities of the Issuer.


ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

     (a)  As of October 17, 2006, funds affiliated with the Reporting Person and
          separately  managed  accounts  over which it  exercises  discretionary
          authority  beneficially  own 1,003,768  shares of the Company's Common
          Stock,  representing  approximately  9.9% of the  outstanding  Common
          Stock (based on 10,172,712 shares reported  outstanding as of July 31,
          2006, as disclosed by the Company in its Form 10Q for the period ended
          June 30, 2006 filed with the Commission on August 8, 2006).

     (c)  The table below sets forth  transactions  in the Issuer's Common Stock
          that the  Reporting  Person  effected  during the past sixty (60) days
          relating to the Issuer. Each transaction set forth below is a sale.



-----------------------------------------------
TRADE DATE   ACTION       QUANTITY     PRICE
-----------------------------------------------

-----------------------------------------------
10/2/06      SELL          5,200       20.0967
-----------------------------------------------
10/4/06      SELL          8,800       18.99
-----------------------------------------------
10/5/06      SELL         11,000       19.1846
-----------------------------------------------
10/6/06      SELL          4,000       19.0628
-----------------------------------------------
10/9/06      SELL          8,280       18.4833
-----------------------------------------------
10/10/06     SELL          9,500       18.5545
-----------------------------------------------
10/11/06     SELL         10,000       18.3399
-----------------------------------------------
10/12/06     SELL         17,500       18.347
-----------------------------------------------
10/13/06     SELL         21,500       18.4227
-----------------------------------------------
10/16/06     SELL         25,000       18.585
-----------------------------------------------
10/17/06     SELL         19,200       18.2978
-----------------------------------------------




Signature

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated:  October 20, 2006

         MELLON HBV ALTERNATIVE STRATEGIES LLC


                  By: /s/ William F. Harley III
                  --------------------------------
                  William F. Harley III
                  Chief Investment Officer